|
Delayed
OTC Markets
12:25:10 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | 0.00% |
|
+3.45% | +15.38% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.95M | - | - | - | - | - |
| 1,054B | |||||
| 636B | - | ||||
| 497B | |||||
| 359B | |||||
| 345B |
Select your edition
All financial news and data tailored to specific country editions
